Verano Holdings (VRNO) Common Equity (2021 - 2026)
Verano Holdings (VRNO) reported Common Equity of $688.3 million for Q1 2026, down 26.9% year-over-year from $941.6 million in Q1 2025, and down 2.25% quarter-over-quarter from $704.2 million in Q4 2025.
Verano Holdings (VRNO) Common Equity (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Common Equity data on file, last reported at $688.3 million in Q1 2026.
- Common Equity for Q1 2026 came in at $688.3 million, down 26.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $688.3 million (down 26.9% YoY), and the FY2025 annual result was $704.2 million, down 25.94% from the prior year.
- Common Equity declined to $688.3 million in Q1 2026 per VRNO's latest filing, from $704.2 million in the prior quarter.
- Over five years, Common Equity peaked at $1.5 billion in Q2 2022 and troughed at $688.3 million in Q1 2026.
- A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2025: Common Equity decreased 7.27% in 2024, then decreased 27.27% in 2025.
- A 5-year view of Common Equity shows it stood at $1.3 billion in 2022, then dropped by 7.56% to $1.2 billion in 2023, then declined by 23.33% to $950.8 million in 2024, then dropped by 25.94% to $704.2 million in 2025, then dropped by 2.25% to $688.3 million in 2026.
- Business Quant data shows VRNO's Common Equity at $688.3 million in Q1 2026, $704.2 million in Q4 2025, and $885.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 688.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 688.35 Mn |
| Dec 31, 2025 | 704.16 Mn |
| Sep 30, 2025 | 885.86 Mn |
| Jun 30, 2025 | 927.23 Mn |
| Mar 31, 2025 | 941.60 Mn |
| Dec 31, 2024 | 950.82 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.24 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.31 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.34 Bn |
| Sep 30, 2022 | 1.54 Bn |
| Jun 30, 2022 | 1.55 Bn |
| Dec 31, 2021 | 1.48 Bn |